Evogene (EVGN) Invested Capital (2016 - 2025)

Evogene (EVGN) has disclosed Invested Capital for 10 consecutive years, with -$82000.0 as the latest value for Q4 2025.

  • Quarterly Invested Capital rose 94.35% to -$82000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$82000.0 through Dec 2025, up 94.35% year-over-year, with the annual reading at -$82000.0 for FY2025, 94.35% up from the prior year.
  • Invested Capital hit -$82000.0 in Q4 2025 for Evogene, up from -$1.5 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $53.7 million in Q4 2021 to a low of -$1.5 million in Q4 2024.
  • Historically, Invested Capital has averaged $18.4 million across 5 years, with a median of $12.1 million in 2023.
  • Biggest five-year swings in Invested Capital: skyrocketed 132.46% in 2021 and later tumbled 112.04% in 2024.
  • Year by year, Invested Capital stood at $53.7 million in 2021, then crashed by 47.94% to $27.9 million in 2022, then tumbled by 56.85% to $12.1 million in 2023, then crashed by 112.04% to -$1.5 million in 2024, then soared by 94.35% to -$82000.0 in 2025.
  • Business Quant data shows Invested Capital for EVGN at -$82000.0 in Q4 2025, -$1.5 million in Q4 2024, and $12.1 million in Q4 2023.